JNJ 64th consecutive dividend increase

PARAGRAPH 1 --- What happened: Johnson & Johnson (JNJ) has raised its quarterly dividend for the 64th consecutive year, increasing the payout to $1.34 per share, a 3% rise from the previous $1.30. This move extends JNJ's dividend growth streak, which began in 1963, and boosts its yield to 3.2%, nearly double the healthcare sector average of 1.8%. The company's consistent dividend growth and attractive yield have drawn income-focused investors.

PARAGRAPH 2 --- Market impact: JNJ's dividend increase and streak have positively impacted income-focused investors and the broader healthcare sector. The company's resilient business model and diversified product portfolio have made it a reliable dividend payer, attracting investors seeking stable income and capital appreciation. The dividend increase also highlights JNJ's strong financial health and ability to generate cash, which can drive further investment in the company's pharmaceutical and consumer health segments.

PARAGRAPH 3 --- What to watch next: Investors should closely monitor JNJ's upcoming Q1 earnings report on April 14, 2023, to assess the company's financial performance and guidance for the remainder of the year. Additionally, they should keep an eye on any regulatory developments related to JNJ's pharmaceutical pipeline and consumer health products, as these could impact the company's growth prospects and dividend payouts. Lastly, investors should watch for any changes in interest rates, which could affect the relative attractiveness of JNJ's dividend yield compared to other income-generating assets.